Anti-citrullinated Protein Antibody-positive Arthralgia Associated with an L110P-E148Q Double Heterozygote: A Case-based Review.

Intern MedFeb 1, 2026 (epub)
Case ReportRheumatology

Kazuhiro Itoh, Hiroshi Tsutani, Nozomi Otsuki et al.

✦ AI-curated · Sources linked

Case in brief

A 42-year-old woman had arthralgia with positive anti-citrullinated protein antibodies and rheumatoid factor but did not initially meet criteria for rheumatoid arthritis. She later developed episodic monoarthritis that responded markedly to colchicine. MEFV testing identified heterozygous L110P and E148Q variants, supporting a colchicine-responsive autoinflammatory condition. She was subsequently diagnosed with rheumatoid arthritis and achieved remission with abatacept and colchicine.

What made this case unusual

The presentation combined rheumatoid arthritis-associated antibodies with episodic, colchicine-responsive monoarthritis and MEFV variants, creating overlapping autoimmune and autoinflammatory features.

Diagnostic / clinical pearl

In antibody-positive arthralgia with episodic monoarthritis, a marked colchicine response and MEFV variants may point to an autoinflammatory component, even when rheumatoid arthritis is not initially established.

Source

Published in Intern Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Rheumatology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.